Pricing Log in Create free account

Adial Pharmaceuticals, Inc. (ADIL) vs Senti Biosciences, Inc. (SNTI)

Adial Pharmaceuticals, Inc. and Senti Biosciences, Inc. are both Biotechnology companies. Adial Pharmaceuticals, Inc. and Senti Biosciences, Inc. are of similar size ($8.3M and $8.1M). Adial Pharmaceuticals, Inc. has the higher net margin (0.00% vs −3,789.3%) and the higher return on invested capital (0.00% vs 0.00%). Across the 11 metrics below, Adial Pharmaceuticals, Inc. leads on 8 and Senti Biosciences, Inc. on 3.

Valuation

Metric ADIL SNTI Biotechnology median
P/E n/m n/m 8.50
P/S n/m 5.24 9.71
P/B n/m n/m 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.22 n/m 0.64
EV/Sales n/m 0.32 9.21
Earnings yield (461.83%) (804.55%) (33.15%)
Free cash flow yield (68.29%) (553.67%) (25.50%)

Profitability

Metric ADIL SNTI Biotechnology median
Gross margin 0.00% 100.00% 65.16%
Operating margin 0.00% (4,181.12%) 0.00%
Net margin 0.00% (3,789.30%) 0.00%
Free cash flow margin 0.00% (2,900.38%) 0.00%
Return on equity 352.60% (466.46%) (56.36%)
Return on assets (322.10%) (97.52%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ADIL SNTI Biotechnology median
Revenue growth (TTM) — (70.73%) 6.02%
EPS growth (last fiscal year) 82.46% 77.31% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric ADIL SNTI Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 5.63 0.83 4.72
Net debt to EBITDA 0.75 0.25 0.96

Dividend

Metric ADIL SNTI Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric ADIL SNTI Biotechnology median
Market cap 8.25m 8.14m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack